Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Bordetella pertussis (Whooping Cough) Tests Market Report Overview

The Bordetella pertussis (Whooping Cough) test market size was $31.7 million in 2023 and will grow at a declining CAGR of less than 1% from 2023 to 2033. Bordetella pertussis (Whooping Cough) tests are carried out to detect infections caused by the bacterium Bordetella pertussis, using a combination of molecular techniques, immunoassay, and other techniques.

Bordetella pertussis (Whooping Cough) Tests Market Outlook 2023-2033 ($ Million)

Buy the Full Report for More Insights into the Bordetella pertussis (Whooping Cough) Tests Market Forecast, Download a Free Sample Report

The Bordetella pertussis (Whooping Cough) tests market research report identifies quantitative market trends within in vitro diagnostics therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the Bordetella pertussis (Whooping Cough) tests market for 2020 and beyond. Furthermore, the report provides Bordetella pertussis (Whooping Cough) tests for market share by a company that will help in identifying untapped market opportunities.

Bordetella pertussis (Whooping Cough) Tests Market Segments

The key segments of the Bordetella pertussis (Whooping Cough) tests market are Bordetella pertussis Nucleic Acid Amplification Tests (NAATs), Bordetella pertussis Other Tests, and Bordetella pertussis Tests Enzyme Immunoassay (EIA) Tests. In 2023, the NAAT segment accounted for the highest share of the Bordetella pertussis (Whooping Cough) tests market.

NAAT involves the amplification of specific nucleic acid sequences of the B. pertussis bacterium by targeting specific nucleic acid sequences. NAAT exhibits better sensitivity in comparison to culture or antigen identification methods. NAAT targets include IS for Bordetella and IS for B. parapertussis. It is commonly used as a confirmatory diagnosis of Whooping Cough.

Bordetella Pertussis (Whooping Cough) Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights into the Bordetella Pertussis (Whooping Cough) Tests Market, Download a Free Sample Report

Bordetella Pertussis (Whooping Cough) Tests Market

The key regions in the Bordetella pertussis (Whooping Cough) tests market are Asia-Pacific, Europe, the Middle East, and Africa. North America and South and Central America are other leading regional markets. In 2023, the North American Bordetella pertussis (Whooping Cough) test market was the leading regional segment.

The Bordetella pertussis tests market will grow in Canada and Mexico and decline in the US during the forecast period. The growth of the Canadian B. pertussis tests markets can be attributed to the increases in the number of incident cases and the number of suspected and confirmatory cases opting for B. pertussis tests. Sales of B. pertussis tests in the US are expected to decline at a minor rate due to a decrease in the number of incident cases.

Bordetella Pertussis (Whooping Cough) Tests Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights into the Bordetella pertussis (Whooping Cough) Tests Market, Download a Free Sample Report

Bordetella pertussis (Whooping Cough) Tests Market – Competitive Landscape

In 2023, Meridian Bioscience Inc Bordetella pertussis (Whooping Cough) tests market share was the highest

The major players in the Bordetella pertussis (Whooping Cough) tests market are:

• bioMerieux SA
• DiaSorin SpA
• Meridian Bioscience Inc
• Quidelortho Corp
• Tecan Group Ltd

Companies may wish to invest in training and education schemes, to promote Bordetella pertussis disease awareness in countries with the potential to implement more comprehensive screening strategies, as well as to familiarize physicians with their brand or type of devices. Similarly, companies may wish to partner with KOLs in countries that currently have high reported rates of Bordetella pertussis infections. This, in turn, can help to determine the potential health and economic benefits of more widespread Bordetella pertussis screening at a population level. In general, companies may wish to focus their product outreach and marketing efforts on countries where primary participants and national guidelines indicate they are more receptive to continuing use of these device types.

Bordetella pertussis (Whooping Cough) Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Bordetella pertussis (Whooping Cough) Tests Market, Download a Free Sample Report

Bordetella pertussis (Whooping Cough) Tests Market Dynamics

• Trends: While culture tests are considered to be the gold standard for diagnosis of Bordetella pertussis, the bacteria can only be recovered from the person during the first three weeks of illness, rendering culturing and DFA useless after this period. The ease of use, stream-lined throughput, and “many birds one stone” approach of multi-parameter NAATs make it an attractive technology for physicians to use.
• Future Outlook: The Bordetella pertussis tests market is expected to increase during the forecast period, largely due to sales increases in the US, Germany, Russia, Australia, China, New Zealand, Brazil, and Saudi Arabia. In North America, Europe, and Asia Pacific, growth will occur in select countries. However, this will outweigh declines in large B. pertussis testing markets such as India and Japan. Another reason is, that there have been fewer vaccinations during the COVID pandemic which will lead to infants and children being more exposed to Pertussis cases.

Purchase the Complete Report for Additional Insights on the Bordetella pertussis (Whooping Cough) Tests Market Dynamics, Get a Free Sample Report Here

Segments Covered in this Report

Bordetella pertussis (Whooping Cough) Tests Segment Outlook ($ Million, 2015-2033)

• Bordetella pertussis Nucleic Acid Amplification Tests (NAATs)
• Bordetella pertussis Other Tests
• Bordetella pertussis Tests Enzyme Immunoassay (EIA) Tests

Bordetella pertussis (Whooping Cough) Tests Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are:

The Bordetella pertussis (Whooping Cough) tests market research report includes an insightful review of the key industry trends.

• The Bordetella pertussis (Whooping Cough) tests market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
• The report also includes market-level data on units, average selling prices, and market values.

Regional, country, and global Bordetella pertussis (Whooping Cough) tests Market Insights:

• The Bordetella pertussis (Whooping Cough) tests market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• Bordetella pertussis (Whooping Cough) tests market SWOT analysis.
• The report provides trends and Bordetella pertussis (Whooping Cough) tests market competitive dynamics.

Buy the Full Report for More Insights on the Bordetella pertussis (Whooping Cough) Tests Market Share, Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies covered: Meridian Biosciences Inc., Hologic Inc., bioMerieux SA, DiaSorin SpA, Quidelortho Corp, Tecan Group Ltd, Qiagen NV, Euroimmun AG, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

• Extensive coverage of the Bordetella pertussis (Whooping Cough) tests market under development.
• An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
• Reviews of major players involved in the development of the Bordetella pertussis (Whooping Cough) tests market and lists all their pipeline projects.
• Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
• Key clinical trial data of ongoing clinical trials specific to pipeline products.
• Recent developments in the segment/industry.

Reasons to Buy

• Understand the COVID-19 impact on Bordetella pertussis (Whooping Cough) tests.
• Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Bordetella pertussis (Whooping Cough) tests.
• Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
• Formulate effective sales and marketing strategies with a detailed evaluation of Bordetella pertussis (Whooping Cough) tests market share by company. Identify strong competitors and create winning strategies to stand out in the global Bordetella pertussis (Whooping Cough) tests market.
• Track regional Bordetella pertussis (Whooping Cough) tests market sales as well as country-specific transactions from 2015-2033.
• Organize your sales and marketing efforts by identifying the global Bordetella pertussis (Whooping Cough) tests market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.